Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	34.16	58.29	43.45
Graham Fair Price	-35.50	3310.75	5132.75
PEG	-499.00	-0.76	-0.13
Price/Book	0.80	0.44	0.44
Price/Cash Flow	62.07	-25.11	15.49
Prices/Earnings	143.95	44.45	18.22
Price/Sales	-1.49	1.26	1.28
Price/FCF	62.07	-25.11	15.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-9.95	0.15	0.17
Operating Margin	-40.56	0.03	0.05
ROA	-59.09	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-58.68
ROIC	< 0.005	< 0.005	-24.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	0.02	35.78
Dividends QOQ	22.69	-0.91	-96.00
EBIT QOQ	-0.51	-0.39	24.32
EPS QOQ	1.44	-0.59	-59.27
FCF QOQ	1.56	-1.62	4.21
Revenue QOQ	-0.15	0.03	-81.91
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.66	67.10	-12.47
Days Sales Outstanding (DSO)	57.38	54.82	-4.45
Inventory Turnover	1.17	1.34	14.25
Debt/Capitalization	0.51	0.51	1.41
Quick Ratio	0.34	0.44	31.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13989.95	19824.23	41.70
Cash	2596.69	2693.82	3.74
Capex	-193.71	371.94	92.00
Free Cash Flow	393.68	-245.69	-37.59
Revenue	4766.77	4894.46	2.68
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.64	0.63	-2.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.63	38.68	35.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating